MX2018001546A - Formulacion y metodo para el tratamiento de la alopecia androgenica. - Google Patents

Formulacion y metodo para el tratamiento de la alopecia androgenica.

Info

Publication number
MX2018001546A
MX2018001546A MX2018001546A MX2018001546A MX2018001546A MX 2018001546 A MX2018001546 A MX 2018001546A MX 2018001546 A MX2018001546 A MX 2018001546A MX 2018001546 A MX2018001546 A MX 2018001546A MX 2018001546 A MX2018001546 A MX 2018001546A
Authority
MX
Mexico
Prior art keywords
weight
treatment
finasteride
minoxidil
baldness
Prior art date
Application number
MX2018001546A
Other languages
English (en)
Inventor
Nacht Sergio
Original Assignee
Centro Int De Cosmiatria S A P I De C V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centro Int De Cosmiatria S A P I De C V filed Critical Centro Int De Cosmiatria S A P I De C V
Priority to MX2018001546A priority Critical patent/MX2018001546A/es
Priority to US16/968,018 priority patent/US20210106519A1/en
Priority to EP19750425.1A priority patent/EP3750542A4/en
Priority to PCT/MX2019/000008 priority patent/WO2019156545A1/es
Publication of MX2018001546A publication Critical patent/MX2018001546A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia

Abstract

La presente invención se refiere a una formulación tópica para usarse en el tratamiento de calvicie androgénica o androgenética tanto en hombres como mujeres con efectos secundarios reducidos, especialmente con menos efectos colaterales en la población femenina. La formulación tópica comprendiendo desde 0.01% hasta 10% en peso de Finasteride y una concentración desde 1% hasta 5% en peso de Minoxidil de forma libre o en un polímero poroso inerte. La combinación del Finasteride y el Minoxidil proporcionando un efecto sinérgico en contra de la calvicie. La formulación además comprende retinol en un 0.15% en peso y estando adaptada para ser administrada en el cuero cabelludo del sujeto en necesidad del mismo.
MX2018001546A 2018-02-06 2018-02-06 Formulacion y metodo para el tratamiento de la alopecia androgenica. MX2018001546A (es)

Priority Applications (4)

Application Number Priority Date Filing Date Title
MX2018001546A MX2018001546A (es) 2018-02-06 2018-02-06 Formulacion y metodo para el tratamiento de la alopecia androgenica.
US16/968,018 US20210106519A1 (en) 2018-02-06 2019-01-31 Formulation and method for the treatment of androgenic alopecia
EP19750425.1A EP3750542A4 (en) 2018-02-06 2019-01-31 FORMULATION AND METHOD FOR THE TREATMENT OF ANDROGENIC ALOPECIA
PCT/MX2019/000008 WO2019156545A1 (es) 2018-02-06 2019-01-31 Formulación y método para el tratamiento de la alopecia androgénica

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2018001546A MX2018001546A (es) 2018-02-06 2018-02-06 Formulacion y metodo para el tratamiento de la alopecia androgenica.

Publications (1)

Publication Number Publication Date
MX2018001546A true MX2018001546A (es) 2019-08-07

Family

ID=67549019

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018001546A MX2018001546A (es) 2018-02-06 2018-02-06 Formulacion y metodo para el tratamiento de la alopecia androgenica.

Country Status (4)

Country Link
US (1) US20210106519A1 (es)
EP (1) EP3750542A4 (es)
MX (1) MX2018001546A (es)
WO (1) WO2019156545A1 (es)

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1201436B (it) * 1985-07-19 1989-02-02 Vincenzo Zappia Formulazioni topiche a lento rilascio
US6495498B2 (en) 1999-05-27 2002-12-17 Johnson & Johnson Consumer Companies, Inc. Detergent compositions with enhanced depositing, conditioning and softness capabilities
EP1154783A4 (en) * 1999-07-06 2005-01-19 Raziel Lurie RELAXIN-CONTAINING MEDICAMENTS AND ITS USE
GB0301577D0 (en) * 2003-01-23 2003-02-26 Edko Pazarlama Tanitim Ltd Sti Topical pharmaceutical and/or cosmetic dispense systems
WO2009101497A2 (en) * 2008-02-11 2009-08-20 Glenmark Pharmaceuticals Limited Topical pharmaceutical combination comprising minoxidil and aminexil
EP2344198B1 (en) * 2008-09-27 2020-11-04 Jina Pharmaceuticals Inc. Lipid based pharmaceutical preparations for topical application
US8470833B2 (en) * 2009-12-15 2013-06-25 Mcneil-Ppc, Inc. Hair growth and/or regrowth compositions
CN103596550A (zh) * 2011-04-25 2014-02-19 朴俊炯 用于预防脱发和促进毛发生长的局部施用的组合物
BR102012022036B1 (pt) * 2012-08-31 2019-10-01 Biolab Sanus Farmacêutica Ltda. Nanopartícula polimérica de finasterida e minoxidil, processo de sua preparação, suspensão aquosa contendo a mesma, composição farmacêutica, e seu uso
WO2014122436A1 (en) * 2013-02-07 2014-08-14 Cipla House Topical pharmaceutical compositions comprising minoxidil
WO2014184173A1 (en) * 2013-05-14 2014-11-20 Montero Gida Sanayi Ve Ticaret A.S. Hair care formulations
CN105106028B (zh) * 2015-08-28 2018-06-19 深圳市维琪医药研发有限公司 一种用于毛发生长的多肽组合物

Also Published As

Publication number Publication date
EP3750542A4 (en) 2022-01-26
EP3750542A1 (en) 2020-12-16
US20210106519A1 (en) 2021-04-15
WO2019156545A1 (es) 2019-08-15

Similar Documents

Publication Publication Date Title
MY199033A (en) Keratin treatment formulations and methods
MX2017014683A (es) Tratamiento para el rebrote del cabello y estimulante del crecimiento.
ZA201701460B (en) Gamma-diketones for treatment and prevention of aging skin and wrinkles
NZ590796A (en) Film-forming liquid formulations for drug release to hair and scalp
PL1863430T3 (pl) Kompozycja oparta na ekstraktach roślinnych z Ajuga reptans do zapobiegania utracie włosów, pobudzania wzrostu włosów i regulacji wytwarzania łoju skórnego
MX362488B (es) Composiciones y metodos para tratar la perdida del cabello y retrasar el envejecimiento de la piel.
WO2018231988A3 (en) COSMETIC COMPOSITIONS AND METHODS FOR USE IN SKIN REFRESH
WO2011059180A3 (ko) 탈모방지 및 두피개선을 위한 두발 화장품 조성물
PH12019501945A1 (en) Composition and method for preventing or delaying onset of myopia comprising atropine
JP2018534337A5 (es)
MX2021013901A (es) Composiciones y métodos para el tratamiento del cáncer.
MX2022002646A (es) Formulacion de ruxolitinib para la reduccion de comezon en dermatitis atopica.
MX2018003086A (es) Composicion que tiene residuo reducido.
SI3057664T1 (en) Use of a composition for pigmentation of hair and hair
MX2018001546A (es) Formulacion y metodo para el tratamiento de la alopecia androgenica.
MX2015009054A (es) Composicion cosmetica o dermatologica que comprende una merocianina, una fase aceitosa y un monoalcanol c1-c4.
MX2017008590A (es) Una composicion aclaradora de la piel que comprende niacinamida e ilomastat.
Murad et al. Prostaglandin analogue for treatment of eyebrow loss in frontal fibrosing alopecia: three cases with different outcomes.
MX2019001852A (es) Metodos y composiciones para reducir el encanecimiento.
MX2020008458A (es) Composicion para la prevencion y el tratamiento de los trastornos del crecimiento del cabello.
MX2021011999A (es) Sulfato de dextrano para afecciones inflamatorias de la piel.
WO2014091146A3 (fr) Utilisation cosmetique d'un extrait de germe de caroube en tant qu'agent actif amincissant
MX2021001090A (es) Extracto de lespedeza capitata para su uso en el campo del cuidado del cabello.
MX2020001317A (es) Una composicion sinergica como un promotor de autofagia.
MX2022007109A (es) Composiciones para el cuidado personal y metodos para estas.